Remus Pharmaceuticals Trust Forecast

Hold candidate since Jul 14, 2026

The Remus Pharmaceuticals Ltd. trust price fell by -1.67% on the last day (Tuesday, 14th Jul 2026) from ₹730.10 to ₹717.90. It has now fallen 6 days in a row. During the last trading day the trust fluctuated 2.74% from a day low at ₹710.50 to a day high of ₹729.95. The price has fallen in 7 of the last 10 days and is down by -7.87% for this period. Volume fell on the last day along with the trust, which is actually a good sign as volume should follow the trust. On the last day, the trading volume fell by -2 thousand shares and in total, 5 thousand shares were bought and sold for approximately ₹3.52 million.

The trust has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at ₹718.83. A reaction back to this level may hold a second chance to get out before further falls.

REMUS.NS Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 5.57%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Remus Pharmaceuticals Ltd. trust holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the trust. On corrections up, there will be some resistance from the lines at ₹751.94 and ₹747.27. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Remus Pharmaceuticals Ltd. trust

Remus Pharmaceuticals Ltd. finds support from accumulated volume at ₹699.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This trust has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the trust moved ₹19.45 between high and low, or 2.74%. For the last week, the trust has had daily average volatility of 3.43%.

Our recommended stop-loss: ₹674.50 (-6.05%) (This trust has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 23 days ago.)

Trading Expectations (REMUS.NS) For The Upcoming Trading Day Of Wednesday 15th

For the upcoming trading day on Wednesday, 15th we expect Remus Pharmaceuticals Ltd. to open at ₹719.45, and during the day (based on 14 day Average True Range), to move between ₹702.39 and ₹733.41, which gives a possible trading interval of +/-₹31.01 (+/-4.42%) up or down from last closing price. If Remus Pharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 4.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at ₹699.80 (2.52%) than the resistance at ₹801.85 (11.69%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Remus Pharmaceuticals Ltd. trust A Buy?

Remus Pharmaceuticals Ltd. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this trust since the last evaluation from a Sell to a Hold candidate.

Current score: -0.286 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on July 15, 2026 - ₹719.45 ( 0.216%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk